CARDINAL HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 103.5 USD | +0.16% |
|
-2.80% | +2.72% |
Presenter SpeechKevin Caliendo (Analysts)All right. Good morning, everybody. I'm Kevin Caliend...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Cardinal Health, Inc. is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows:
- distribution of pharmaceutical products (92.7%);
- distribution of medical, surgical and laboratory products (7.3%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic products, products of aspiration and collection of liquids, radiology intervention, respiratory assistance, etc.).
The United States accounts for 97.7% of net sales.
Sector
Pharmaceuticals
Calendar
2024-05-01
- Q3 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
103.5
USD
Average target price
112.9
USD
Spread / Average Target
+9.07%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.72% | 25.18B | |
| +15.65% | 70.36B | |
| +6.36% | 8.61B | |
| +6.10% | 8.14B | |
| -21.85% | 7.83B | |
| 0.00% | 4.56B | |
| +17.40% | 4.32B | |
| -0.14% | 4.06B | |
| -2.61% | 3.87B | |
| +21.03% | 3.61B |
- Stock Market
- Equities
- CAH Stock
- News Cardinal Health, Inc.
- Transcript : Cardinal Health, Inc. Presents at UBS Global Healthcare Conference, May-25-2022 08
